Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine

HongWu Sun,1,* Chao Wei,1,* BaoShuai Liu,1 HaiMing Jing,1 Qiang Feng,2 YaNan Tong,1 Yun Yang,1 LiuYang Yang,1 QianFei Zuo,1 Yi Zhang,1 QuanMing Zou,1 Hao Zeng1 1National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sun HW, Wei C, Liu BS, Jing HM, Feng Q, Tong YN, Yang Y, Yang LY, Zuo QF, Zhang Y, Zou QM, Zeng H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/354992f7b6c64fad9450bacafde3979a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:354992f7b6c64fad9450bacafde3979a
record_format dspace
spelling oai:doaj.org-article:354992f7b6c64fad9450bacafde3979a2021-12-02T03:11:40ZInduction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine1178-2013https://doaj.org/article/354992f7b6c64fad9450bacafde3979a2015-12-01T00:00:00Zhttps://www.dovepress.com/induction-of-systemic-and-mucosal-immunity-against-methicillin-resista-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013HongWu Sun,1,* Chao Wei,1,* BaoShuai Liu,1 HaiMing Jing,1 Qiang Feng,2 YaNan Tong,1 Yun Yang,1 LiuYang Yang,1 QianFei Zuo,1 Yi Zhang,1 QuanMing Zou,1 Hao Zeng1 1National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University of Chinese PLA, 2Department of Biological and Chemical Engineering, Chongqing University of Education, Chongqing, People’s Republic of China *These authors contributed equally to this work Abstract: The Gram-positive bacterial pathogen methicillin-resistant Staphylococcus aureus (MRSA) can cause infections in the bloodstream, endocardial tissue, respiratory tract, culture-confirmed skin, or soft tissue. There are currently no effective vaccines, and none are expected to become available in the near future. An effective vaccine capable of eliciting both systemic and mucosal immune responses is also urgently needed. Here, we reported a novel oil-in-water nanoemulsion adjuvant vaccine containing an MRSA recombination protein antigen, Cremophor EL-35® as a surfactant, and propylene glycol as a co-surfactant. This nanoemulsion vaccine, whose average diameter was 31.34±0.49 nm, demonstrated good protein structure integrity, protein specificity, and good stability at room temperature for 1 year. The intramuscular systemic and nasal mucosal immune responses demonstrated that this nanoemulsion vaccine could improve the specific immune responses of immunoglobulin (Ig)G and related subclasses, such as IgG1, IgG2a, and IgG2b, as well as IgA, in the serum after Balb/c mice intramuscular immunization and C57 mice nasal immunization. Furthermore, this nanoemulsion vaccine also markedly enhanced the interferon-γ and interleukin-17A cytokine cell immune response, improved the survival ratio, and reduced bacterial colonization. Taken together, our results show that this novel nanoemulsion vaccine has great potential and is a robust generator of an effective intramuscular systemic and nasal mucosal immune response without the need for an additional adjuvant. Thus, the present study serves as a sound scientific foundation for future strategies in the development of this novel nanoemulsion adjuvant vaccine to enhance both the intramuscular systemic and nasal mucosal immune responses. Keywords: nanotechnology, adjuvant, methicillin-resistant Staphylococcus aureus, recombination protein, immune responsesSun HWWei CLiu BSJing HMFeng QTong YNYang YYang LYZuo QFZhang YZou QMZeng HDove Medical PressarticleNanoemulsionAdjuvantMethicillin-resistant Staphylococcus aureusSystemic immuneMucosal immune.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 7275-7290 (2015)
institution DOAJ
collection DOAJ
language EN
topic Nanoemulsion
Adjuvant
Methicillin-resistant Staphylococcus aureus
Systemic immune
Mucosal immune.
Medicine (General)
R5-920
spellingShingle Nanoemulsion
Adjuvant
Methicillin-resistant Staphylococcus aureus
Systemic immune
Mucosal immune.
Medicine (General)
R5-920
Sun HW
Wei C
Liu BS
Jing HM
Feng Q
Tong YN
Yang Y
Yang LY
Zuo QF
Zhang Y
Zou QM
Zeng H
Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine
description HongWu Sun,1,* Chao Wei,1,* BaoShuai Liu,1 HaiMing Jing,1 Qiang Feng,2 YaNan Tong,1 Yun Yang,1 LiuYang Yang,1 QianFei Zuo,1 Yi Zhang,1 QuanMing Zou,1 Hao Zeng1 1National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University of Chinese PLA, 2Department of Biological and Chemical Engineering, Chongqing University of Education, Chongqing, People’s Republic of China *These authors contributed equally to this work Abstract: The Gram-positive bacterial pathogen methicillin-resistant Staphylococcus aureus (MRSA) can cause infections in the bloodstream, endocardial tissue, respiratory tract, culture-confirmed skin, or soft tissue. There are currently no effective vaccines, and none are expected to become available in the near future. An effective vaccine capable of eliciting both systemic and mucosal immune responses is also urgently needed. Here, we reported a novel oil-in-water nanoemulsion adjuvant vaccine containing an MRSA recombination protein antigen, Cremophor EL-35® as a surfactant, and propylene glycol as a co-surfactant. This nanoemulsion vaccine, whose average diameter was 31.34±0.49 nm, demonstrated good protein structure integrity, protein specificity, and good stability at room temperature for 1 year. The intramuscular systemic and nasal mucosal immune responses demonstrated that this nanoemulsion vaccine could improve the specific immune responses of immunoglobulin (Ig)G and related subclasses, such as IgG1, IgG2a, and IgG2b, as well as IgA, in the serum after Balb/c mice intramuscular immunization and C57 mice nasal immunization. Furthermore, this nanoemulsion vaccine also markedly enhanced the interferon-γ and interleukin-17A cytokine cell immune response, improved the survival ratio, and reduced bacterial colonization. Taken together, our results show that this novel nanoemulsion vaccine has great potential and is a robust generator of an effective intramuscular systemic and nasal mucosal immune response without the need for an additional adjuvant. Thus, the present study serves as a sound scientific foundation for future strategies in the development of this novel nanoemulsion adjuvant vaccine to enhance both the intramuscular systemic and nasal mucosal immune responses. Keywords: nanotechnology, adjuvant, methicillin-resistant Staphylococcus aureus, recombination protein, immune responses
format article
author Sun HW
Wei C
Liu BS
Jing HM
Feng Q
Tong YN
Yang Y
Yang LY
Zuo QF
Zhang Y
Zou QM
Zeng H
author_facet Sun HW
Wei C
Liu BS
Jing HM
Feng Q
Tong YN
Yang Y
Yang LY
Zuo QF
Zhang Y
Zou QM
Zeng H
author_sort Sun HW
title Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine
title_short Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine
title_full Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine
title_fullStr Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine
title_full_unstemmed Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine
title_sort induction of systemic and mucosal immunity against methicillin-resistant staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/354992f7b6c64fad9450bacafde3979a
work_keys_str_mv AT sunhw inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT weic inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT liubs inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT jinghm inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT fengq inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT tongyn inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT yangy inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT yangly inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT zuoqf inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT zhangy inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT zouqm inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
AT zengh inductionofsystemicandmucosalimmunityagainstmethicillinresistantstaphylococcusaureusinfectionbyanovelnanoemulsionadjuvantvaccine
_version_ 1718401845453389824